Bolashak residents will have access to a vaccine approved by WHO

Fellows of the Bolashak program are provided with access to a vaccine approved by the World Health Organization. This issue, at the request of the Ministry of Education and Science, was considered at a meeting of the Interim Commission to prevent the emergence and spread of coronavirus infection. Azattyq Rýhy.

As a result, the IAC allowed the fellows to be vaccinated with a vaccine approved by WHO. Thanks to this decision, Bolashak scholarship holders will be able to travel freely to countries where access is allowed only upon receipt of WHO-approved vaccines.

As of November 8, 2021, only those vaccinated with WHO-approved vaccines will be allowed entry into the United States. Note that this list includes vaccines from Pfizer/BioNTech, Moderna, Johnson&, Johnson, AstraZeneca, Covishield, BIBP/Sinopharm, Sinovac. Similar rules also apply to entry into Australia and a number of other countries.

“In order to avoid disrupting the start of training for Bolashak scholarship holders who are waiting to travel to Australia, Canada, New Zealand, the United States and Japan for training or internships, the MES sent a letter to the Ministry of Health to consider the possibility of providing them with a vaccine approved by WHO. Note that entry into the territory of these countries requires a full vaccination with two doses of drugs approved by WHO. The MVK supported our proposal. As a result, vaccination with the BIBP/Sinopharm vaccine is allowed,” said Vice Minister of Education and Science of the Republic of Kazakhstan Kuanysh Yergaliyev.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.